Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. BROKER RATINGS SUMMARY: Investec Starts Wolseley With Hold Rating

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Investec Starts Wolseley With Hold Rating

Wed, 12th Oct 2016 08:27

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
TRADERS: INVESTEC INITIATES WOLSELEY WITH 'HOLD'
----------
DEUTSCHE BANK RAISES SHIRE PRICE TARGET TO 6200 (6000) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES GLAXOSMITHKLINE PRICE TARGET TO 1870 (1800) PENCE - 'HOLD'
----------
DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 6200 (5800) PENCE - 'BUY'
----------
TRADERS: MERRILL LYNCH REMOVES BT GROUP FROM 'EUROPE 1 LIST'
----------
GOLDMAN RAISES VODAFONE PRICE TARGET TO 275 (265) PENCE - 'NEUTRAL'
----------
UBS RAISES BURBERRY PRICE TARGET TO 1800 (1650) PENCE - 'BUY'
----------
FTSE 250
----------
HSBC RAISES PAGEGROUP PRICE TARGET TO 385 (320) PENCE - 'HOLD'
----------
BARCLAYS RAISES PAGEGROUP PRICE TARGET TO 390 (340) PENCE - 'EQUAL WEIGHT'
----------
GOLDMAN RAISES PAGEGROUP PRICE TARGET TO 347 (333) PENCE - 'SELL'
----------
TRADERS: KEPLER CHEUVREUX RAISES PAGEGROUP TO 'HOLD' ('REDUCE')
----------
LIBERUM RAISES ASHMORE GROUP TO 'HOLD' ('SELL') - PRICE TARGET 379 (240) PENCE
----------
DEUTSCHE BANK RAISES ZOOPLA PROPERTY PRICE TARGET TO 300 (280) PENCE - 'HOLD'
----------
Investec Lifts OneSavings Bank Target To 360p From 355p, Keeps At Buy
----------
Cantor Fitzgerald Cuts Sports Direct Target To 260p From 320p, Hold
----------
BERENBERG RAISES VICTREX PRICE TARGET TO 1650 (1510) PENCE - 'HOLD'
----------
CITIGROUP RAISES ELECTROCOMPONENTS TO 'NEUTRAL' ('SELL') - PRICE TARGET 375 PENCE
----------
MAIN MARKET AND AIM
----------
DAVY CUTS PREMIER FOODS TO 'NEUTRAL' ('OUTPERFORM')
----------
PANMURE RAISES ANIMALCARE GROUP PRICE TARGET TO 370 (337) PENCE - 'BUY'
----------
N+1 Lifts Walker Greenbank To Buy From Hold, Target 250p From 200p
----------
LIBERUM CUTS MELROSE INDUSTRIES TO 'HOLD' ('BUY') - PRICE TARGET 200 PENCE
----------
GOLDMAN RAISES SECURE INCOME PRICE TARGET TO 370 (308) PENCE - 'NEUTRAL'
----------

PANMURE CUTS VERNALIS PLC PRICE TARGET TO 65 (76) PENCE - 'BUY'

---------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.